1. Sorafenib in the Treatment of Hepatocellular Carcinoma
   欣 姚, 2020, Advances in Clinical Medicine CrossRef
2. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
   Xinyao Hu et al, 2021, Frontiers in Oncology CrossRef
3. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
   Zhi Zeng et al, 2021, Frontiers in Oncology CrossRef
4. LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells
   Jing Sun et al, 2022, Acta Biochimica et Biophysica Sinica CrossRef
5. FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
   Wenyue Shen et al, 2022, Frontiers in Oncology CrossRef
6. Relationship between FBXW7 and the Occurrence of Primary Liver Cancer
   智勇 谭, 2021, Advances in Clinical Medicine CrossRef
7. MiR-223 as a Regulator and Therapeutic Target in Liver Diseases
   Jiarong Gu et al, 2022, Frontiers in Immunology CrossRef